Relationship between adiponectin level, insulin sensitivity, and metabolic syndrome in type 1 diabetic patients

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Blaslov, Kristina ^a   Bulum, Tomislav ^a   Zibar, Karin ^a   Duvnjak, Lea ^a  

^a University of Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VENOUS BLOOD; WAIST CIRCUMFERENCE;

EID: 84881441552     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/535906     Document Type: Article

References (43)

1. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology & Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
2. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005 (Pubitemid 40686653)
3. Okamoto Y., Kihara S., Funahashi T., Matsuzawa Y., Libby P., Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science 2006 110 3 267 278 2-s2.0-33644770179 10.1042/CS20050182 (Pubitemid 43341630)
4. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.-I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 1 79 83 2-s2.0-0033515761 10.1006/bbrc.1999.0255 (Pubitemid 29299050)
5. Yatagai T., Nagasaka S., Taniguchi A., Fukushima M., Nakamura T., Kuroe A., Nakai Y., Ishibashi S., Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003 52 10 1274 1278 2-s2.0-0242304261 10.1016/S0026- 0495(03)00195-1 (Pubitemid 37351094)
6. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., Funahashi T., Adiponectin as a biomarker of the metabolic syndrome. Circulation Journal 2004 68 11 975 981 2-s2.0-9144244319 10.1253/circj.68.975 (Pubitemid 39540124)
7. Daimon M., Oizumi T., Saitoh T., Kameda W., Hirata A., Yamaguchi H., Ohnuma H., Igarashi M., Tominaga M., Kato T., Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: The Funagata Study. Diabetes Care 2003 26 7 2015 2020 2-s2.0-1642467862 10.2337/diacare.26.7.2015 (Pubitemid 41184244)
8. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M., Taskinen M.-R., Groop L., Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 4 683 689 2-s2.0-0034837376 (Pubitemid 32893993)
9. Okamoto Y., Arita Y., Nishida M., Muraguchi M., Ouchi N., Takahashi M., Igura T., Inui Y., Kihara S., Nakamura T., Yamashita S., Miyagawa J., Funahashi T., Matsuzawa Y., An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Hormone and Metabolic Research 2000 32 2 47 50 2-s2.0-0034014647 (Pubitemid 30143606)
10. Frystyk J., Tarnow L., Krarup Hansen T., Parving H.-H., Flyvbjerg A., Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005 48 9 1911 1918 2-s2.0-24944545643 10.1007/s00125-005-1850-z (Pubitemid 41317848)
11. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., Hildebrandt P., Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005 112 12 1756 1762 2-s2.0-25444506344 10.1161/CIRCULATIONAHA.104.530972 (Pubitemid 41372115)
12. Ghosh S., Collier A., Hair M., Malik I., Elhadd T., Metabolic syndrome in type 1 diabetes. International Journal of Diabetes Mellitus 2010 2 1 38 42 2-s2.0-77749332003 10.1016/j.ijdm.2009.10.005
13. Orchard T. J., Olson J. C., Erbey J. R., Williams K., Forrest K. Y.-Z., Kinder L. S., Ellis D., Becker D. J., Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care 2003 26 5 1374 1379 2-s2.0-0042168839 10.2337/diacare.26.5.1374 (Pubitemid 36929165)
14. Reaven G. M., Role of insulin resistance in human disease. Diabetes 1988 37 12 1595 1607 2-s2.0-0024160877 (Pubitemid 19004941)
15. Williams K. V., Erbey J. R., Becker D., Arslanian S., Orchard T. J., Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000 49 4 626 632 2-s2.0-0034112259 (Pubitemid 30183752)
16. IDF Consensus Worldwide Definition of the Metabolic Syndrome. 2006
17. Wanders D., Plaisance E. P., Judd R. L., Pharmacological effects of lipid-lowering drugs on circulating adipokines. World Journal of Diabetes 2010 1 4 116 128
18. Teupe B., Bergis K., Epidemiological evidence for 'double diabetes'. The Lancet 1991 337 8737 361 362 2-s2.0-0026021142
19. Chillarón J. J., Goday A., Flores-Le-Roux J. A., Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism 2009 94 9 3530 3534
20. Thorn L. M., Forsblom C., Fagerudd J., Thomas M. C., Pettersson-Fernholm K., Saraheimo M., Wadén J., Rönnback M., Rosengärd-Bärlund M., Björkesten C.-G. A., Taskinen M.-R., Groop P.-H., Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane Study). Diabetes Care 2005 28 8 2019 2024 2-s2.0-23044481147 10.2337/diacare.28.8.2019 (Pubitemid 41060978)
21. Saraheimo M., Teppo A.-M., Forsblom C., Fagerudd J., Groop P.-H., Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 2003 46 10 1402 1407 2-s2.0-0142061945 10.1007/s00125-003-1194-5 (Pubitemid 37297211)
22. Santaniemi M., Kesäniemi Y. A., Ukkola O., Low plasma adiponectin concentration is an indicator of the metabolic syndrome. European Journal of Endocrinology 2006 155 5 745 750 2-s2.0-33845238731 10.1530/eje.1.02287 (Pubitemid 44857499)
23. Pereira R. I., Snell-Bergeon J. K., Erickson C., Schauer I. E., Bergman B. C., Rewers M., Maahs D. M., Adiponectin dysregulation and insulin resistance in type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism 2012 97 4 E642 E647 2-s2.0-84859541050 10.1210/jc.2011-2542
24. Pham M. N., Kolb H., Mandrup-Poulsen T., Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin. Diabetes/Metabolism Research and Reviews 2013 29 2 166 170
25. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005 (Pubitemid 40686653)
26. Fang X., Sweeney G., Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochemical Society Transactions 2006 34 5 798 801 2-s2.0-33751276007 10.1042/BST0340798 (Pubitemid 44796424)
27. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., Noda T., Disruption of adiponectin causes insulin resistance and neointimal formation. The Journal of Biological Chemistry 2002 277 29 25863 25866 2-s2.0-0037135523 10.1074/jbc.C200251200 (Pubitemid 34967064)
28. Berg A. H., Combs T. P., Du X., Brownlee M., Scherer P. E., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001 7 8 947 953 2-s2.0-0034881391 10.1038/90992 (Pubitemid 32756433)
29. Kriketos A. D., Gan S. K., Poynten A. M., Furler S. M., Chisholm D. J., Campbell L. V., Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 2004 27 2 629 630 2-s2.0-0842333064 10.2337/diacare.27.2. 629 (Pubitemid 38174107)
30. Kim E. S., Im J.-A., Kim K. C., Park J. H., Suh S.-H., Kang E. S., Kim S. H., Jekal Y., Lee C. W., Yoon Y.-J., Lee H. C., Jeon J. Y., Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity 2007 15 12 3023 3030 2-s2.0-39149131036 10.1038/oby.2007.360 (Pubitemid 351256664)
31. Kazumi T., Kawaguchi A., Sakai K., Hirano T., Yoshino G., Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002 25 6 971 976 2-s2.0-0036598335 10.2337/diacare.25.6.971 (Pubitemid 41110480)
32. Cnop M., Havel P. J., Utzschneider K. M., Carr D. B., Sinha M. K., Boyko E. J., Retzlaff B. M., Knopp R. H., Brunzell J. D., Kahn S. E., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003 46 4 459 469 2-s2.0-0038293399 (Pubitemid 36577787)
33. Tschritter O., Fritsche A., Thamer C., Haap M., Shirkavand F., Rahe S., Staiger H., Maerker E., Häring H., Stumvoll M., Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003 52 2 239 243 2-s2.0-0037312826 10.2337/diabetes.52.2.239 (Pubitemid 36173174)
34. Blanco-Colio L. M., Martín-Ventura J. L., Gómez-Guerrero C., Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk. European Journal of Pharmacology 2008 586 1-3 259 265
35. Tomkin G. H., Owens D., LDL as a cause of atherosclerosis. The Open Atherosclerosis & Thrombosis Journal 2012 5 13 21
36. Soedamah-Muthu S. S., Chang Y.-F., Otvos J., Evans R. W., Orchard T. J., Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2003 46 5 674 682 2-s2.0-0037677153 (Pubitemid 36808187)
37. Lamarche B., Moorjani S., Cantin B., Dagenais G. R., Lupien P. J., Després J.-P., Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men: prospective results from the Quebec cardiovascular study. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 6 1098 1105 2-s2.0-0030610965 (Pubitemid 27260329)
38. Bulum T., Kolarić B., Duvnjak L., Lower levels of total HDL and HDL3 cholesterol are associated with albuminuria in normoalbuminuric type 1 diabetic patients. Journal of Endocrinological Investigation 2013 10.3275/8850
39. Baden M. Y., Yamada Y., Takahi Y., Association of adiponectin with blood pressure in healthy people. Clinical Endocrinology 2013 78 2 226 231
40. Shatat I. F., Freeman K. D., Vuguin P. M., Dimartino-Nardi J. R., Flynn J. T., Relationship between adiponectin and ambulatory blood pressure in obese adolescents. Pediatric Research 2009 65 6 691 695 2-s2.0-67049159752 10.1203/PDR.0b013e31819ea776
41. Chow W.-S., Cheung B. M. Y., Tso A. W. K., Xu A., Wat N. M. S., Fong C. H. Y., Ong L. H. Y., Tam S., Tan K. C. B., Janus E. D., Lam T.-H., Lam K. S. L., Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007 49 6 1455 1461 2-s2.0-34249298701 10.1161/HYPERTENSIONAHA.107.086835 (Pubitemid 46809394)
42. Fruebis J., Tsao T.-S., Javorschi S., Ebbets-Reed D., Erickson M. R. S., Yen F. T., Bihain B. E., Lodish H. F., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the National Academy of Sciences of the United States of America 2001 98 4 2005 2010 2-s2.0-0035852760 10.1073/pnas.041591798 (Pubitemid 32165613)
43. López-Bermejo A., Botas P., Funahashi T., Delgado E., Kihara S., Ricart W., Fernández-Real J. M., Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clinical Endocrinology 2004 60 2 256 263 2-s2.0-1042276559 10.1046/j.1365-2265.2004.01977.x (Pubitemid 38200909)